Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-02-14
2008-10-28
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000
Reexamination Certificate
active
07442683
ABSTRACT:
A novel cyclic peptide having an antifungal activity, its pharmacologically acceptable salts and antifungal medicinal compositions containing the same.
REFERENCES:
patent: 4401656 (1983-08-01), Failli et al.
patent: 4409210 (1983-10-01), Kawaguchi et al.
patent: 4533631 (1985-08-01), Kawaguchi et al.
patent: 5171836 (1992-12-01), Yoshida et al.
patent: 5830855 (1998-11-01), Takemoto
patent: 199 33 173 A 1 (2001-01-01), None
patent: 0 084 826 (1983-08-01), None
patent: 3127798 (1991-05-01), None
patent: 5279384 (1993-10-01), None
patent: WO 95/30692 (1995-11-01), None
patent: 0105815 (2001-01-01), None
Jamison, James et al., “Syntheses and Antifungal Activity of Pseudomycin Side-Chain Analogues. Part I.”,Bioorganic&Medicinal Chemistry Letters, vol. 10, No. 18, Sep. 18, 2000, p. 2101-2105 XP004208321.
Awazu Naoyuki
Kato Ikunoshin
Kurome Toru
Takesako Kazutoh
Browdy and Neimark PLLC
Takara Bio Inc.
Tate Christopher R.
Teller Roy
LandOfFree
Cyclic peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004981